CEO Kevin Smith told investors at the KeyBanc Conference that the company has spent the past two years stabilizing operations ...
The FDA approved a proximal hypoglossal nerve stimulation device (aura6000 system) for adults with moderate to severe obstructive sleep apnea (OSA), maker LivaNova announced on Thursday. FDA's ...
LivaNova's aura6000 system delivers synchronised electrical pulses to the hypoglossal nerve to prevent airways collapse in ...
Escalating to extrafine single-inhaler triple therapy significantly reduces exacerbations in patients with moderate to severe COPD.
Verywell Health on MSN
The hormone and blood sugar disruption caused by OSA, according to an endocrinologist
Fact checked by Jennifer Klump About the Author Kelly Wood, MD, is a board-certified endocrinologist specializing in osteoporosis and metabolic bone disease. She also treats adults with diabetes, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results